Industry & Mining · Pharmaceutical active pharmaceutical ingredients (APIs) production

Pharmaceutical active pharmaceutical ingredients (APIs) production in Australia in 2026

In 2026, Australia did not produce active pharmaceutical ingredients — the figure was 200 tonnes. The country, renowned for its biotech research, imports finished APIs from China and India, while local pharma companies specialize in finished dosage forms and vaccines at plants in Melbourne and Sydney.

Data for 2026 · unit: tonnes
Position

Australia world ranking

#7 / 197

Country position on the scale from last to first place for this indicator.

AU
#7
#197#1
Trend

Change over time

Change in indicator over the available period.

10
1950
150
1990
200
2000
250
2010
300
2020
180
2025
200
2026

Values — tonnes

Comparison

Top countries by Pharmaceutical active pharmaceutical ingredients (APIs) production

Where Australia stands in the world ranking.

Full world rankingarrow_forward
Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical active pharmaceutical ingredients (APIs) production in Australia — how much?
Based on 2026 data — 200 tonnes. This is rank #7 out of 197 countries.
What is Australia's rank by Pharmaceutical active pharmaceutical ingredients (APIs) production?
Australia ranks #7 out of 197 countries in the world ranking by «Pharmaceutical active pharmaceutical ingredients (APIs) production».
How has Pharmaceutical active pharmaceutical ingredients (APIs) production changed in Australia?
Over the available period the indicator changed from 10 to 200 tonnes.